Invention Grant
- Patent Title: Crystal forms of crenolanib and methods of use thereof
-
Application No.: US17326433Application Date: 2021-05-21
-
Publication No.: US11713310B2Publication Date: 2023-08-01
- Inventor: Vinay Jain
- Applicant: Arog Pharmaceuticals, Inc.
- Applicant Address: US TX Dallas
- Assignee: Arog Pharmaceuticals, Inc.
- Current Assignee: Arog Pharmaceuticals, Inc.
- Current Assignee Address: US TX Dallas
- Agency: Foley Hoag LLP
- Agent Dana M. Gordon; Laura Wzorek
- Main IPC: C07D405/14
- IPC: C07D405/14
Abstract:
The present invention relates to novel crystalline polymorphs of 1-[2-[5-[(3-Methyl-3-oxetanyl)methoxy]-1H-benzimidazol-1-yl]-8-quinolinyl]-4-piperidinamine monobenzenesulfonate, and to methods for their preparation. The invention further relates to pharmaceutical compositions containing one or more forms and optionally one or more suitable pharmaceutical carriers. The invention also relates to methods of using the crystalline polymorphs of the invention in the treatment of disease.
Public/Granted literature
- US20220017500A1 CRYSTAL FORMS OF CRENOLANIB AND METHODS OF USE THEREOF Public/Granted day:2022-01-20
Information query
